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We used both linear regression analyses to look for associations with
variations in the WOMAC scores. Signiﬁcantly higher WOMAC scores
(worse disease) were seen in older people, women, those with obesity,
those with worse general health, and most strikingly, those with lower
educational attainment. The radiographic severity showed no association
with WOMAC scores.
Major differences between countries were not apparent.
Conclusions:
1. In advanced hip OA clinical severity shows no associationwith radio-
graphic severity.
2. Disease severity varies widely at the time of THR for OA. However, the
variation in clinical severity is much greater than that for radiographic
severity, suggesting that while patients reporting mild symptoms may
be operated on, surgery is unlikely in the absence of severe radio-
graphic changes.
3. Simple scores of pain and disability, such as the WOMAC, do not
reﬂect the complexity of decision making about who should have a
THR. The decision needs to involve a large number of psychosocial
and personal issues as well as disease severity.
555 RATES OF REVISION OF PRIMARY TOTAL HIP
REPLACEMENT IN A POPULATION BASED COHORT: ROLE
OF PATIENT GENDER AND SURGEON VOLUME
J.N. Katz, E.A. Wright, E. Losina. Brigham and Women’s Hospital,
Boston, MA, USA
Purpose: Over 250,000 primary total hip replacements are performed
annually in the US. Failure of the implant, often leading to revision THR
is a well recognized complication. However, rates of failure of primary
THR, leading to revision, have not been ascertained in population based
cohorts in the US. The objective of this research is to examine rates of
revision in the eight years following a primary THR in a population based
sample stratiﬁed by gender, surgeon volume and time since primary THR.
Methods: We used Medicare claims to follow a cohort of all 57,488
Medicare beneﬁciaries that had a primary, elective THR for non-fracture
indications between July 1995 and June 1996. We identiﬁed revision
THR on the basis of ICD-9 codes in Medicare claims data over the
subsequent 8 years. Patients were censored at death and at the time
of a second primary THR. We categorized surgeon annual THR volume
as <12, 12−24 and >24 THR cases per year. Early revisions were deﬁned
as those occurring in the ﬁrst 12 months postoperatively. We calculated
the annual rate of THR in each surgeon volume stratum, stratiﬁed by
early vs. later period of follow-up and by patient gender.
Results: 3,616 of the 57,488 THR recipients had a revision THR over
the subsequent 8 years. Revision rates were much higher (up to 2%)
in the early period (ﬁrst 12 months) than over the subsequent years of
follow-up, when they hovered around 1% per year (Figure). Volume had
a strong association with early revision rates, with patients of low volume
surgeons much more likely to have an early revision than patients of
higher volume surgeons. Volume had little effect on later revision rates.
Men had 10−20% higher revision rates compared to women.
Conclusions: These are the ﬁrst population based data in the US on
8-year rates of revision following primary THR. Surgeon volume has a
dramatic effect on early revisions and males have somewhat higher rates
of early and later revision. Whether this gender effect is due to greater
rates of failure of THR in men (due to weight and activity, for example)
or differential rates of being offered and of accepting revision surgery
requires further study.
556 POLY-D,L-LACTIDE-CO-GLYCOLIDE RESORBABLE
SCAFFOLDS IN THE TREATMENT OF OSTEOCHONDRAL
TALUS DOME DEFECTS
F. Sciarretta, P. Versari, A. Basile, A. Ruo, E. Di Cave. Jewish Hospital
of Rome, Rome, ITALY
Purpose: The purpose of the present study is to evaluate the efﬁcacy of
synthetic resorbable scaffolds transplantation of the talar dome with MRI
and clinical short-term follow-up. We therefore present surgical technique
steps and early results at one year obtained with preformed in shape and
size bone graft substitutes in repair of III and IV degree full thickness
osteochondral defects of the talus.
Methods: The utilized implant is a cylinder composed of poly(D,L-lactide-
co-glycolide) to which calcium sulphate and surfactant are added to
enhance bone in-growth and make implant’s surface more hydrophilic.
The three-dimensional porous cylindrical implant with interconnected
pores is press ﬁt into the site for close apposition and encourage migration
of repair tissue as blood and marrow into the scaffold. The two layer
construct of the implantmimics the mechanics of the surrounding tissues,
bone and cartilage, in order to facilitate from the beginning the nature of
the repair tissue that will be formed. The plugs are available in different
sizes (5, 7, 9mm) are preformed in order to match the talus dome
surfaces. The ﬁrst 15 patients were included in the study (7 women,
8 men). Every patient has underwent arthroscopic ankle asse ssment
to evaluate size, location and degree of defects and has underwent im-
plantation of TruﬁtTM cylindrical resorbable scaffold. Majority of synthetic
bone substitutes implanted were 7mm in diameter.
Results: All surgical procedures have been completed uneventfully.
Patient have been controlled clinically and by serial ankle MRI’s and
showed statistically signiﬁcant improvement of AOFAS scores associated
to healing of defect and integration of bone plugs in absence of adverse
reactions.
Conclusions: Today several methods are available for surgical treatment
of hyaline cartilage defects frequently incidentally encountered during
arthroscopies, especially in the knee, as reported by various authors. At
our institution, among other treatments, we recently have decided to use
TruﬁtTM synthetic implants, retaining interesting to use a scaffold that
enables bone and hyaline like cartilage in-growth before of its resorp-
tion. Preliminary results enable us to conclude that porous, resorbable
scaffolds can be used in treatment of cartilage defects offering a secure
support to secondary bone in-growth with the advantage of being applied
in one single step procedure, enabling patients to quickly move back to
previous daily and sport activities.
557 DEVELOPMENT OF SPINE OSTEOARTHRITIS AFTER
POSTERIOR LUMBAR SPINE INTERBODY FUSION
L. Me´cs, G. Soha´r, K. To´th. University of Szeged, Szeged, HUNGARY
Purpose: The purpose of this study was to evaluate the development
of osteoarthritis in the neighboring segment after posterior lumbar spine
interbody fusion (PLIF) procedures.
The disc acts as a shock absorber in between the vertebrae, whereas
the paired facet joints restrain motion. As the facet joints age, they can
become incompetent and allow too much ﬂexion, allowing one vertebral
body to slip forward on the other. This slippage is known as a degenerative
spondylolisthesis. PLIF is a procedure used to treat problems of spine
instability. The goal of the procedure is to stimulate the vertebrae to fuse
together. The fusion creates a rigid and immovable column of bone in the
problem section of the spine.
Methods: Between 1994 and 1999, we treated 128 consecutive patients
(54 women) with PLIF performed by excision of the facet joints and pedicle
screw ﬁxation. Their mean age at the time of surgery was 40 years.
The mean follow-up period was 10.9 years. Disorders treated by this
procedure included degenerative and isthmic spondylolisthesis.
The follow-up examination included the Oswestry outcome measure,
physical assessment, and radiological evaluation.
Results: Evaluation based on the Oswestry disability index before and
after the operation showed a marked improvement from average 358 to
224 point. Unfortunately, the average outcome index rose to 238 after
ﬁve years and 286 at ten years time due to degenerative pathology in the
neighboring segments. On the x-ray examination progressively increasing
facet joint osteoarthritis was seen over the years.
Conclusions: Until very recently, there was no data on the long-term
outcome of interbody fusion. At postoperative follow-up, patients who
underwent surgery had signiﬁcantly better scores for both pain and daily
function. The beneﬁts were reduced after ten years. Spinal fusion for
